19.45
+0.20
+(1.04%)
At close: 1:30:39 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
82,620.00
34,599.00
136,976.00
111,658.00
118,273.00
Investing Cash Flow
-74,280.00
-75,374.00
-82,732.00
-153,071.00
6,779.00
Financing Cash Flow
9,551.00
-36,817.00
-91,085.00
-61,367.00
-49,330.00
End Cash Position
85,475.00
55,595.00
133,687.00
169,953.00
274,846.00
Capital Expenditure
-42,678.00
-35,540.00
-70,933.00
-117,116.00
-138,986.00
Issuance of Capital Stock
--
2,814.00
--
669.00
--
Issuance of Debt
72,603.00
22,698.00
--
--
--
Repurchase of Capital Stock
--
--
--
--
-62,400.00
Free Cash Flow
39,942.00
-941.00
66,043.00
-5,458.00
-20,713.00
12/31/2020 - 9/19/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
33.20
+0.30%
1733.TW Apex Biotechnology Corp.
29.95
0.00%
1734.TW Sinphar Pharmaceutical Co.,Ltd.
30.75
+0.33%
6885.TW BRIM Biotechnology, Inc.
28.90
-2.03%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
3118.TWO Level Biotechnology Inc.
32.35
-0.15%
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%